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Table – Main characteristics
067
Prognostic significance of calibrated integrated backscatter in patients
with heart failure and preserved ejection fraction
Bertrand D’Héré (1), Dimitri Stepowski (1), Charlotte Vallet (1), Baptiste
Kurtz (1), Vincent Richard (2), Jean-Nicolas Dacher (1), Helene Eltchani-
noff (1), Fabrice Bauer (1)
(1) CHU de Rouen hôpital Charles icole, cardiologie, Rouen, France –
(2) UFR médecine pharmacie Unité Inserm 10 96, Rouen, France
Introduction: Calibrated integrated backscatter (CIB), a surrogate for
myocardial fibrosis, is deteriorated in hypertrophic, ischemic cardiomyopathy
or in systolic heart failure (HF). Whether CIB may differentiate patients with
heart failure and preserved ejection fraction (HFPEF) at risk of death or HF
reoccurrence has never been investigated.
Methods: 34 patients admitted for HFPEF (Framingham criteria, EF >50%
and BNP level >100 pg/ml) were imaged by echocardiography 2 months fol-
lowing an acute decompensation. We measured left ventricular function, atrial
dimensions and calibrated Integrated Backscatter (CIB) which was obtained
from parasternal long axis by subtracting pericardial CIB intensity from myo-
cardial CIB intensity of the LV anteroseptal and posterior walls (figure). Mea-
surements of calibrated CIB, expressed in decibels, were performed at QRS
complex onset. The primary endpoint was the occurrence of death or hospital-
ization for HF at 12-month F/U.
Results: 11 patients reached the primary endpoint (3 deaths and 8 hos-
pitalizations for HF). In this group at risk, patients had more chronic
obstructive pulmonary disease (p=0.03) and coronary artery bypass
(p=0.008). Despite similar EF (55,7±7,3 vs. 61,5±10,8 p=0,25), we
observed larger left atrial diameter (49.5 mm±6.6 vs. 44.2 mm±7.0 p=0.05)
and area (28.8±6.2 cm² vs. 24.5±5.1 cm², p=0.044) in patients with endpoint
vs. no endpoint. Patients with clinical endpoint showed more anteroseptal
and posterior wall myocardial ultrasound reflectivity (–12.8 dB±7.4 vs. –22.7 dB±
8.1 p=0.0017 and –14.8±5.7 vs. 21.3+/-8.0 p=0.021) as compared with
event-free patients.
Conclusion: Our data support the hypothesis that calibrated CIB, a surro-
gate for myocardial fibrosis, identifies HFPEF patients at risk of death or HF
hospitalization.
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Pulmonary hypertension in patients older than 70 years with preserved
left ventricular function and no valvular heart disease
Clarisse Menager, Sophie Tassan Mangina, Sarah Ledon, Pierre Nazeyrollas,
Roland Jaussaud, Damien Metz
CHU Robert Debré, Reims, France
Introduction: Pulmonary hypertension (PH) is frequent among elderly
patients. The most common causes of PH in this population are severe valve
diseases and heart failure with decreased left ventricular ejection fraction
(LVEF). PH in older patients without valve disease and with preserved LVEF
is less known: the aim of our study was to determine the characteristics of
older patients with PH despite preserved LVEF and normal valves.
Methods: We included prospectively patients over 70 year of age, with PH
suspected during echocardiography and confirmed by pressure measurements
during right heart catheterization. The exclusion criteria were significant valve
disease and LVEF under 50%.
Results: Between November 2010 and November 2011, we included 26
consecutive patients (17 women), 78±5 years old with systolic pulmonary
arterial pressure of 68±15 mm Hg. Nineteen patients (73%) had been hospital-
ized for heart failure previously and 59% were in NYHA III-IV functional
class. The six-minute walk distance was 226±132 m, the mean NT-proBNP
level 1462 pg/ml. Fourteen patients (54%) had atrial fibrillation. Nine patients
Mediane
 [25 – 75th pctl]
AAr+ 
= 313 (58.5%)
AAr-
=220 (41.5%)
p-value
Age 80[73-84] 77[70-84] 0.003
Body Mass Index 28[24-32] 25[25-33] ns
Left ventricular 
ejection fraction
55 [50-60] 55[50-60] ns
Systolic blood 
pressure (mm Hg)
144[125-160] 151[132-180] 0.0002
NT-proBNP 
admission
2654 [1356-4921] 2113 [1040-4630] 0.06
NT-proBNP 4-8 
weeks
1710 [819- 2800] 2113 [1040- 1948] <0.001
Figure (abstract 067) – Integrated backscatter measurement
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